V vs ZYME · P/E 33, rev $40.00B vs rev $76.3M
Visa Inc. Class A (V) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
V currently screens at market cap $659.78B and trailing P/E 33.5. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the V and ZYME stock pages for the full models.
Not investment advice.